Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

POLR3B-associated leukodystrophy: clinical, neuroimaging and molecular-genetic analyses in four patients: clinical heterogeneity and novel mutations in POLR3B gene

J. Kulhánek, K. Brožová, H. Hansíková, A. Vondráčková, V. Stránecký, J. Šenkyřík, S. Kmoch, J. Zeman, T. Honzík, M. Tesařová,

. 2019 ; 53 (5) : 369-376. [pub] 20191002

Language English Country Poland

Document type Journal Article

INTRODUCTION AND AIM OF THE STUDY: White matter disorders represent a spectrum of neurological diseases frequently associated with an unfavourable prognosis and a delay in diagnostics. We report the broad phenotypic spectrum of a rare hypomyelinating leukodystrophy and three novel mutations. Further, we aim to explore the role of the combined clinical and neuroimaging diagnostic approach in the era of whole exome sequencing. MATERIALS AND METHODS: We present a clinical, neuroimaging and molecular-genetic characterisation of four patients from three families suffering from a rare genetic leukoencephalopathy. Two severely affected siblings (P1, P2) manifested a profound developmental delay, cerebellar symptomatology, microcephaly, failure to thrive, short stature and delayed teeth eruption with oligodontia. The other two patients (P3, P4), on the contrary, suffer from substantially less serious impairment with mild to moderate developmental delay and cerebellar symptomatology, delayed teeth eruption, or well-manageable epilepsy. In all four patients, magnetic resonance revealed cerebellar atrophy and supratentorial hypomyelination with T2-weight hypointensities in the areas of the ventrolateral thalamic nuclei, corticospinal tract and the dentate nuclei. RESULTS: Using whole-exome sequencing in P1, P2 and P3, and targeted sequencing in P4, pathogenic variants were disclosed in POLR3B, a gene encoding one of 17 subunits of DNA-dependent RNA polymerase III - all patients were compound heterozygotes for point mutations. Three novel mutations c.727A>G (p.Met243Val) and c.2669G>A (p.Arg890His) (P1, P2), and c.1495G>A (p.Met499Val) (P3) were found. Magnetic resonance revealed the characteristic radiological pattern of POLR3-leukodystrophies in our patients. CONCLUSION AND CLINICAL IMPLICATIONS: The diagnosis of POLR3-associated leukodystrophies can be significantly accelerated using the combined clinical and neuroradiological recognition pattern. Therefore, it is of crucial importance to raise the awareness of this rare disorder among clinicians. Molecular-genetic analyses are indispensable for a swift diagnosis confirmation in cases of clear clinical suspicion, and for diagnostic search in patients with less pronounced symptomatology. They represent an invaluable tool for unravelling the complex genetic background of heritable white matter disorders.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044513
003      
CZ-PrNML
005      
20240627092353.0
007      
ta
008      
200109s2019 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/PJNNS.a2019.0042 $2 doi
035    __
$a (PubMed)31577365
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Kulhánek, Jan $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic. $7 xx0319239
245    10
$a POLR3B-associated leukodystrophy: clinical, neuroimaging and molecular-genetic analyses in four patients: clinical heterogeneity and novel mutations in POLR3B gene / $c J. Kulhánek, K. Brožová, H. Hansíková, A. Vondráčková, V. Stránecký, J. Šenkyřík, S. Kmoch, J. Zeman, T. Honzík, M. Tesařová,
520    9_
$a INTRODUCTION AND AIM OF THE STUDY: White matter disorders represent a spectrum of neurological diseases frequently associated with an unfavourable prognosis and a delay in diagnostics. We report the broad phenotypic spectrum of a rare hypomyelinating leukodystrophy and three novel mutations. Further, we aim to explore the role of the combined clinical and neuroimaging diagnostic approach in the era of whole exome sequencing. MATERIALS AND METHODS: We present a clinical, neuroimaging and molecular-genetic characterisation of four patients from three families suffering from a rare genetic leukoencephalopathy. Two severely affected siblings (P1, P2) manifested a profound developmental delay, cerebellar symptomatology, microcephaly, failure to thrive, short stature and delayed teeth eruption with oligodontia. The other two patients (P3, P4), on the contrary, suffer from substantially less serious impairment with mild to moderate developmental delay and cerebellar symptomatology, delayed teeth eruption, or well-manageable epilepsy. In all four patients, magnetic resonance revealed cerebellar atrophy and supratentorial hypomyelination with T2-weight hypointensities in the areas of the ventrolateral thalamic nuclei, corticospinal tract and the dentate nuclei. RESULTS: Using whole-exome sequencing in P1, P2 and P3, and targeted sequencing in P4, pathogenic variants were disclosed in POLR3B, a gene encoding one of 17 subunits of DNA-dependent RNA polymerase III - all patients were compound heterozygotes for point mutations. Three novel mutations c.727A>G (p.Met243Val) and c.2669G>A (p.Arg890His) (P1, P2), and c.1495G>A (p.Met499Val) (P3) were found. Magnetic resonance revealed the characteristic radiological pattern of POLR3-leukodystrophies in our patients. CONCLUSION AND CLINICAL IMPLICATIONS: The diagnosis of POLR3-associated leukodystrophies can be significantly accelerated using the combined clinical and neuroradiological recognition pattern. Therefore, it is of crucial importance to raise the awareness of this rare disorder among clinicians. Molecular-genetic analyses are indispensable for a swift diagnosis confirmation in cases of clear clinical suspicion, and for diagnostic search in patients with less pronounced symptomatology. They represent an invaluable tool for unravelling the complex genetic background of heritable white matter disorders.
650    12
$a nemoci mozečku $7 D002526
650    12
$a dědičné demyelinizační nemoci CNS $7 D020279
650    _2
$a lidé $7 D006801
650    _2
$a mutace $7 D009154
650    _2
$a neurozobrazování $7 D059906
650    _2
$a RNA-polymerasa III $x genetika $7 D012320
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brožová, Klára $u Department of Pediatric Neurology, Thomayer Hospital, Prague, Czech Republic,, Vídeňská 800, 14059 Prague, Czech Republic.
700    1_
$a Hansíková, Hana $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Vondráčková, Alžběta $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Stránecký, Viktor $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Šenkyřík, Jan $u Department of Pediatric Radiology, University Hospital Brno, Czech Republic, Jihlavská 20, 62500 Brno, Czech Republic.
700    1_
$a Kmoch, Stanislav $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Zeman, Jiří $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Honzík, Tomáš $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic.
700    1_
$a Tesařová, Markéta $u Clinic of Pediatric and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12109 Prague, Czech Republic. marketa.tesarova@vfn.cz.
773    0_
$w MED00003489 $t Neurologia i neurochirurgia polska $x 0028-3843 $g Roč. 53, č. 5 (2019), s. 369-376
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31577365 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20240627092347 $b ABA008
999    __
$a ok $b bmc $g 1482782 $s 1083186
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 53 $c 5 $d 369-376 $e 20191002 $i 0028-3843 $m Neurologia i Neurochirurgia Polska $n Neurol Neurochir Pol $x MED00003489
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...